Evidence map›Paper›PMID 24993766›Full record

ArticleBMJ open2014

Lifetime alcohol use and overall and cause-specific mortality in the European Prospective Investigation into Cancer and nutrition (EPIC) study.

Pietro Ferrari, Idlir Licaj, David C Muller, Per Kragh Andersen, Mattias Johansson, Heiner Boeing, Elisabete Weiderpass, Laure Dossus, Laureen Dartois, Guy Fagherazzi and 29 more

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in BMJ open, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed, 5 pooled it
6.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 5 syntheses or guidelines pooled it, 106 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Observational
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

39 authors at 20 institutions in 13 countries.

Pietro FerrariInternational Agency for Research on Cancer, Lyon, France.
Idlir LicajInternational Agency for Research on Cancer, Lyon, France.
David C MullerInternational Agency for Research on Cancer, Lyon, France.
Per Kragh AndersenDepartment of Biostatistics, University of Copenhagen, Copenhagen, Denmark.
Mattias JohanssonInternational Agency for Research on Cancer, Lyon, France.
Heiner BoeingPotsdam-Rehbrücke Department of Epidemiology, German Institute of Human Nutrition, Nuthetal, Germany.
Elisabete WeiderpassDepartment of Community Medicine, Faculty of Health Sciences, University of Tromso, The Arctic University of Norway, Tromsø, Norway Department of Research, Cancer Registry of Norway, Oslo, Norway Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden Samfundet Folkhälsan, Helsinki, Finland.
Laure DossusInserm, Centre for research in Epidemiology and Population Health (CESP), U1018, Nutrition, Hormones and Women's Health team, Villejuif, France Université Paris Sud, UMRS 1018, Villejuif, France IGR, Villejuif, France.
Laureen DartoisInserm, Centre for research in Epidemiology and Population Health (CESP), U1018, Nutrition, Hormones and Women's Health team, Villejuif, France Université Paris Sud, UMRS 1018, Villejuif, France IGR, Villejuif, France.
Guy FagherazziInserm, Centre for research in Epidemiology and Population Health (CESP), U1018, Nutrition, Hormones and Women's Health team, Villejuif, France Université Paris Sud, UMRS 1018, Villejuif, France IGR, Villejuif, France.
Kathryn E BradburyCancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0003-3345-7333
Kay-Tee KhawDepartment of Public Health and Primary Care, University of Cambridge Addenbrooke's Hospital, Cambridge, UK.
Nick WarehamMedical Research Council Epidemiology Unit, Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, UK.
Eric J DuellUnit of Nutrition, Cancer Epidemiology Research Program, Environment and Cancer, Bellvitge Biomedical Research Institute (IDIBELL), Catalan Institute of Oncology (ICO), Barcelona, Spain.
Aurelio BarricarteNavarre Public Health Institute, Pamplona, Spain Consortium for Biomedical Research in Epidemiology and Public Health (CIBER Epidemiología y Salud Pública-CIBERESP), Murcia, Spain.
Esther Molina-MontesEscuela Andaluza de Salud Pública, Instituto de Investigación Biosanitaria de Granada, Granada, Spain CIBER Epidemiología y Salud Pública (CIBERESP), Spain.
Carmen Navarro SanchezCIBER Epidemiología y Salud Pública (CIBERESP), Spain Department of Epidemiology, Murcia Regional Health Council, Murcia, Spain Department of Health and Social Sciences, Universidad de Murcia, Murcia, Spain.
Larraitz ArriolaConsortium for Biomedical Research in Epidemiology and Public Health (CIBER Epidemiología y Salud Pública-CIBERESP), Murcia, Spain Public Health Division of Gipuzkoa, Instituto BIO-Donostia, Basque Government, Spain.
Peter WallströmNutrition Epidemiology Research Group, Department of Clinical Sciences, Lund University, Malmö, Sweden.
Anne TjønnelandDanish Cancer Society Research Center, Copenhagen, Denmark.
Anja OlsenDanish Cancer Society Research Center, Copenhagen, Denmark.
Antonia TrichopoulouDepartment of Hygiene, Epidemiology and Medical Statistics, WHO Collaborating Center for Food and Nutrition Policies, University of Athens Medical School, Athens, Greece Hellenic Health Foundation, Athens, Greece.
Vasiliki BenetouDepartment of Hygiene, Epidemiology and Medical Statistics, WHO Collaborating Center for Food and Nutrition Policies, University of Athens Medical School, Athens, Greece.
Dimitrios TrichopoulosHellenic Health Foundation, Athens, Greece Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, USA Bureau of Epidemiologic Research, Academy of Athens, Athens, Greece.
Rosario TuminoCancer Registry and Histopathology Unit, "Civic-MP Arezzo" Hospital, ASP Ragusa, Italy.
Claudia AgnoliEpidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Carlotta SacerdoteUnit of Cancer Epidemiology, AO Citta' della Salute e della Scienza-University of Turin and Center for Cancer Prevention (CPO-Piemonte), Turin, Italy Human Genetics Foundation (HuGeF), Turin, Italy.
Domenico PalliMolecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Institute-ISPO, Florence, Italy.
Kuanrong LiDepartment of Cancer Epidemiology, German Cancer Research Centre, Heidelberg, Germany.
Rudolf KaaksDepartment of Cancer Epidemiology, German Cancer Research Centre, Heidelberg, Germany.
Petra PeetersDepartment of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center, Utrecht, The Netherlands.
Joline Wj BeulensDepartment of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center, Utrecht, The Netherlands.
Luciana NunesInternational Agency for Research on Cancer, Lyon, France Department of Statistics, Federal University of Rio Grande do Sul, Porto Alegre, Brazil.
Marc GunterDepartment of Epidemiology & Biostatistics, School of Public Health, Imperial College London, London, UK.
Teresa NoratDepartment of Epidemiology & Biostatistics, School of Public Health, Imperial College London, London, UK.
Kim OvervadDepartment of Public Health, Section for Epidemiology, Aarhus University, Aarhus, Denmark Department of Cardiology, Aalborg University Hospital, Aalborg, Denmark.
Paul BrennanInternational Agency for Research on Cancer, Lyon, France.
Elio RiboliDepartment of Epidemiology & Biostatistics, School of Public Health, Imperial College London, London, UK.
Isabelle RomieuInternational Agency for Research on Cancer, Lyon, France.
Centre international de recherche sur le cancer · FRImperial College London · GBUniversité Paris-Sud · FRDanish Cancer Society · DKGerman Cancer Research Center · DENational and Kapodistrian University of Athens · GRUniversity Medical Center Utrecht · NLAarhus University · DKAddenbrooke's Hospital · GBAzienda Usl 8 Arezzo · ITBasque Government · ESFondazione IRCCS Istituto Nazionale dei Tumori · ITGerman Institute of Human Nutrition · DEHarvard University · USInstitut d'Investigació Biomédica de Bellvitge · ESInstituto de Investigación Biosanitaria de Granada · ESInstituto de Salud Pública de Navarra · ESItalian institute for Genomic Medicine · ITKarolinska Institutet · SELund University · SE

Funding

Cancer Research UK 14136Cancer Research UK 16491Medical Research Council G0401527Medical Research Council G1000143World Health Organization 001
6 · The paper itself

Abstract

objectivesTo investigate the role of factors that modulate the association between alcohol and mortality, and to provide estimates of absolute risk of death.

designThe European Prospective Investigation into Cancer and nutrition (EPIC).

setting23 centres in 10 countries.

participants380 395 men and women, free of cancer, diabetes, heart attack or stroke at enrolment, followed up for 12.6 years on average.

main outcome measures20 453 fatal events, of which 2053 alcohol-related cancers (ARC, including cancers of upper aerodigestive tract, liver, colorectal and female breast), 4187 cardiovascular diseases/coronary heart disease (CVD/CHD), 856 violent deaths and injuries. Lifetime alcohol use was assessed at recruitment.

resultsHRs comparing extreme drinkers (≥30 g/day in women and ≥60 g/day in men) to moderate drinkers (0.1-4.9 g/day) were 1.27 (95% CI 1.13 to 1.43) in women and 1.53 (1.39 to 1.68) in men. Strong associations were observed for ARC mortality, in men particularly, and for violent deaths and injuries, in men only. No associations were observed for CVD/CHD mortality among drinkers, whereby HRs were higher in never compared to moderate drinkers. Overall mortality seemed to be more strongly related to beer than wine use, particularly in men. The 10-year risks of overall death for women aged 60 years, drinking more than 30 g/day was 5% and 7%, for never and current smokers, respectively. Corresponding figures in men consuming more than 60 g/day were 11% and 18%, in never and current smokers, respectively. In competing risks analyses, mortality due to CVD/CHD was more pronounced than ARC in men, while CVD/CHD and ARC mortality were of similar magnitude in women.

conclusionsIn this large European cohort, alcohol use was positively associated with overall mortality, ARC and violent death and injuries, but marginally to CVD/CHD. Absolute risks of death observed in EPIC suggest that alcohol is an important determinant of total mortality.

Indexed as

Cause of DeathAdultAgedAlcohol DrinkingCardiovascular DiseasesEuropeFemaleHumansMaleMiddle AgedNeoplasmsProspective StudiesRisk AssessmentTime FactorsCardiologyNutrition & Dietetics

Identifiers

PMID24993766
PMCPMC4091394
OpenAlexW2171583333

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.